Treatment of virally induced lesions
US9895334B2 · kind B2 · utility
0Cited by
1References
85Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 30, 2008 |
| Grant date | Feb 20, 2018 |
| Priority date | — |
| Expiry date | Feb 17, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/0034
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates generally to the treatment of cutaneous lesions containing cells infected by a virus, as well as compositions for the treatment of such lesions. More specifically, the invention relates to the use of ingenol compounds, particularly ingenol angelates, in treating lesions caused by infection with a papilloma virus, such as a mammalian papilloma virus, in particular a Human Papilloma Virus.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.